Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|June 15, 2000
Ifosfamide and vinorelbine in advanced pretreated ovarian cancer: a phase II studyM Nardi, S De Marco, A Fabi, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 31, 2014
Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: effect of 12-month growth hormone replacement therapyS De Marco, M L Marcovecchio, D Caniglia, et al.
Journal of Thoracic Imaging|April 29, 1998
Segmental pulmonary arteries: two-dimensional and three-dimensional time-of-flight magnetic resonance angiographyM Scialpi, C Scapati, A Carriero, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2001
Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I studyM Nardi, S De Marco, A Fabi, et al.
La Radiologia Medica|June 1, 1996
[Pulmonary artery: angiographic technique optimization with magnetic resonance]A Carriero, N Magarelli, M Baratto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II studyA Falcone, E Pfanner, S Ricci, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 1991
Clinical spectrum of accidental hemlock poisoning: neurotoxic manifestations, rhabdomyolysis and acute tubular necrosisD Rizzi, C Basile, A Di Maggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?P Carlini, A Frassoldati, S De Marco, et al.
Pageof 3